Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

Journal of Clinical and Aesthetic Dermatology

Volumn 6, Issue 3, 2013, Pages 29-33

  Choudhary, Sonal ^a   McLeod, Michael ^a   Torchia, Daniele ^a   Romanelli, Paolo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; COMPLEMENT COMPONENT C3; DONEPEZIL; FIBRIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE;

APATHY; BASAL GANGLION; BRAIN ANGIOGRAPHY; BRAIN STEM; CADASIL; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEMENTIA; GENETIC SCREENING; HUMAN; LACUNAR STROKE; MIGRAINE; MOOD DISORDER; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PROPHYLAXIS; REHABILITATION; REVIEW; SKIN BIOPSY; SMOOTH MUSCLE FIBER; SOCIAL SUPPORT; SUBCORTEX; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

EID: 84876175134     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993;3: 256-259.
2. Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the First International Workshop on CADASIL. Paris, May 19-21, 1993. Stroke. 1994;25: 704-707.
3. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383: 707-710.
4. Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry. 2005;76: 739-741.
5. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a mendelian condition causing stroke and vascular dementia. Ann N Y Acad Sci. 1997;826: 213-217.
6. Dotti MT, Federico A, Mazzei R, et al. The spectrum of Notch3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry. 2005;76: 736-738.
7. Peters N, Opherk C, Bergmann T, et al. Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol. 2005;62: 1091-1094.
8. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350: 1511-1515.
9. Federico A, Bianchi S, Dotti MT. The spectrum of mutations for CADASIL diagnosis. Neurol Sci. 2005;26: 117-124.
10. Joutel A, Dodick DD, Parisi JE, et al. De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol. 2000;47: 388-391.
11. Ebke M, Dichgans M, Bergmann M, et al. CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand. 1997;95: 351-357.
12. Goebel HH, Meyermann R, Rosin R, Schlote W. Characteristic morphologic manifestation of CADASIL, cerebral autosomaldominant arteriopathy with subcortical infarcts and leukoencephalopathy, in skeletal muscle and skin. Muscle Nerve. 1997;20: 625-627.
13. Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346: 934-939.
14. Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44: 731-739.
15. Desmond DW, Moroney JT, Lynch T, et al The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 1999;30: 1230-1233.
16. Reyes S, Viswanathan A, Godin O, et al. Apathy: a major symptom in CADASIL. Neurology. 2009;72: 905-910.
17. Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology. 1998;51: 452-457.
18. Dichgans M, Filippi M, Bruning R, et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology. 1999;52: 1361-1367.
19. Choi EJ, Choi CG, Kim JS. Large cerebral artery involvement in CADASIL. Neurology. 2005;65: 1322-1324.
20. Dichgans M, Petersen D. Angiographic complications in CADASIL. Lancet. 1997;349: 776-777.
21. Monet M, Domenga V, Lemaire B, et al. The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo. Hum Mol Genet. 2007;16: 982-992.
22. LaPoint SF, Patel U, Rubio A. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Adv Anat Pathol. 2000;7: 307-321.
23. Ruchoux MM, Guerouaou D, Vandenhaute B, et al. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. 1995;89: 500-512.
24. Ruchoux MM, Chabriat H, Bousser MG, Baudrimont M, Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke. 1994;25: 2291-2292.
25. Schroder J, Sebold V, Isenberg C, et al. Eels-analysis revealed negative metal and mineral evidence in GOM-deposits in a CADASIL patient (Abstract). J Invest Dermatol. 2000;115: 929.
26. Rubio A, Rifkin D, Powers JM, et al. Phenotypic variability of CADASIL and novel morphologic findings. Acta Neuropathol. 1997;94: 247-254.
27. Ruchoux MM, Maurage CA. Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurobiol. 1998;24: 60-65.
28. Walsh JS, Perniciaro C, Meschia JF. CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy): diagnostic skin biopsy changes determined by electron microscopy. J Am Acad Dermatol. 2000;43: 1125-1127.
29. Ratzinger G, Ransmayr G, Romani N, Zelger B. CADASIL-an unusual manifestation with prominent cutaneous involvement. Br J Dermatol. 2005;152: 346-349.
30. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. CADASIL. Lancet Neurol. 2009;8: 643-653.
31. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke. 1993;24: 122-125.
32. Maclean AV, Woods R, Alderson LM, et al. Spontaneous lobar haemorrhage in CADASIL. J Neurol Neurosurg Psychiatry. 2005;76: 456-457.
33. Ragoschke-Schumm A, Axer H, Fitzek C, et al. Intracerebral haemorrhage in CADASIL. J Neurol Neurosurg Psychiatry. 2005;76: 1606-1607.
34. Dichgans M, Markus HS, Salloway S, et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol. 2008;7: 310-318.
35. Chabriat H, Joutel A, Vahedi K, et al. [CADASIS. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalophathy]. Rev Neurol (Paris). 1997;153: 376-385.
36. Desmond DW, Moroney JT, Lynch T, et al. CADASIL in a North American family: clinical, pathologic, and radiologic findings. Neurology. 1998;51: 844-849.
37. Vahedi K, Chabriat H, Levy C, et al. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol. 2004;61: 1237-1240.
38. Peters N, Herzog J, Opherk C, Dichgans M. A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke. 2004;35: 1603-1608.
39. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain. 2004;127: 2031-2038.
40. Chabriat H, Tournier-Lasserve E, Vahedi K, et al. Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology. 1995;45: 1086-1091.
41. Chabriat H, Joutel A, Vahedi K, et al. [CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy): clinical features and neuroimaging]. Bull Acad Natl Med. 2000;184: 1523-1531; discussion 31-33.
42. Buffon F, Porcher R, Hernandez K, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry. 2006;77: 175-180.
43. Taillia H, Chabriat H, Kurtz A, Verin M, Levy C, Vahedi K, et al. Cognitive alterations in non-demented CADASIL patients. Cerebrovasc Dis. 1998;8: 97-101.
44. Peters N, Opherk C, Danek A, et al. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry. 2005;162: 2078-2085.
45. Hedera P, Friedland RP. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: study of two American families with predominant dementia. J Neurol Sci. 1997;146: 27-33.
46. Blanco Menendez R, Aguado Balsas AM, Blanco E, Lobo Rodriguez B, Vera De La Puente E. [The CADASIL syndrome: a model of subcortical-cortical disconnection]. Rev Neurol. 2001;32: 750-754.
47. Tatsch K, Koch W, Linke R, et al. Cortical hypometabolism and crossed cerebellar diaschisis suggest subcortically induced disconnection in CADASIL: an 18F-FDG PET study. J Nucl Med. 2003;44: 862-869.
48. O'Sullivan M, Barrick TR, Morris RG, Clark CA, Markus HS. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology. 2005;65: 1584-1590.
49. Felician O, Barbeau E, Gavaret M, et al. A case of late-onset CADASIL with interhemispheric disconnection features. J Neurol. 2003;250: 1242-1244.
50. Herve D, Chabriat H. Cadasil. J Geriatr Psychiatry Neurol. 2010;23: 269-276.
51. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Longterm prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127: 2533-2539.
52. Malandrini A, Carrera P, Ciacci G, et al. Unusual clinical features and early brain MRI lesions in a family with cerebral autosomal dominant arteriopathy. Neurology. 1997;48: 1200-1203.